Role of bronchoscopy in lung cancer research

Clinics in Chest Medicine

Volumn 20, Issue 1, 1999, Pages 191-199

  Baughman, R P ^a   Pina, E M ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER RESEARCH; HUMAN; IMMUNE RESPONSE; LUNG CANCER; LUNG LAVAGE; PRIORITY JOURNAL; REVIEW;

EID: 0032903652     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70134-9     Document Type: Article

References (97)

1. S.M. Aguayo M.A. Kane T.E. King Jr Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers J Clin Invest 84 1989 1105 1113
2. M.C. Ahn K.P. Siziopikou J.M. Plate Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6 Cancer Immunol Immunother 45 1997 37 44
3. J.N. Allen S.A. Moore A.L. Pope Harman Immunosuppressive properties of surfactant and plasma on alveolar macrophages J Lab Clin Med 125 1995 356 369
4. A. Ardizzoni M. Bonavia M. Viale Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer Caner 73 1994 1353 1360
5. J. Bates R. Rutherford M. Divilly Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer Eur Respir J 10 1997 2535 2538
6. R.P. Baughman The uncertainties of bronchoalveolar lavage Eur Respir J 10 1997 1940 1942
7. R.P. Baughman S. Strohofer Lung derived surface active material (SAM) inhibits natural killer cell tumor cytotoxicity J Clin Lab Immunol 28 1989 51 54
8. P.A. Bejarano R.P. Baughman P.W. Biddinger Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas Mod Pathol 9 1996 445 452
9. S.E. Benner S.M. Lippman W.K. Hong Chemoprevention of lung cancer Chest 107 1995 316S 321S
10. R. Biyoudi Vouenze A. Tazi A.J. Hance Abnormal epithelial cells recovered by bronchoalveolar lavage: Are they malignant? Am Rev Respir Dis 142 1990 686 690
11. T.L. Bonfield M.W. Konstan P. Burfeind Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis Am J Respir Cell Mol Biol 13 1995 257 261
12. P. Borron R.A. Veldhuizen J.F. Lewis Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production Am J Respir Cell Mol Biol 15 1996 115 121
13. A.M. Brown E.T. Lally A. Frankel The association of the IgA levels of serum and whole saliva with the progression of oral cancer Cancer 35 1975 1154 1162
14. A.E. Calogero R. Polosa E. Neville Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer J Endocrinol Invest 18 1995 354 358
15. O. Capelli E. Rovatti F. Gilioli BAL modifications after antiblastic and immunomodulant therapy in lung cancer Respiration 59 suppl 1 1992 50 52
16. Y.M. Chen W.K. Yang J. Whang Peng Elevation of interleukin-10 levels in malignant pleural effusion Chest 110 1996 433 436
17. Y.M. Chen W.K. Yang J. Whang Peng Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients J Immunother 20 1997 354 364
18. J.Y. Cho J.H. Kim Y.H. Lee Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma Cancer 79 1997 462 467
19. N.C. Clements Jr M.A. Nelson J.A. Wymer Analysis of K-ras gene mutations in malignant and nonmalignant endobronchial tissue obtained by fiberoptic bronchoscopy Am J Respir Crit Care Med 152 1995 1374 1378
20. R.G. Crystal A. Jaffe S. Brody A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung Hum Gene Ther 6 1995 643 666
21. A. de Diego L. Compte J. Sanchis Usefulness of carcinoembryonic antigen determination in bronchoalveolar lavage fluid. A comparative study among patients with peripheral lung cancer, pneumonia, and healthy individuals Chest 100 1991 1060 1063
22. E.S. de Lustig E. Matos C. Spector Secretory IgA content in human normal and tumoral bronchial mucosa in vitro Oncology 37 1980 16 19
23. P.B. Dent P.B. McCullouch O. Wesley-Jones Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma Cancer 42 1978 1484 1491
24. C. Di Loreto V. Di Lauro F. Puglisi Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma J Clin Pathol 50 1997 30 32
25. M.N. Dohn R.P. Baughman Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease Am Rev Respir Dis 132 1985 390 392
26. R. Fletcher Carcinoembryonic antigen Ann Intern Med 104 1986 66 73
27. R.S. Fontana M.R. Melkamed J.K. Frost Early lung cancer detection: summary and conclusions Am Rev Respir Dis 130 1984 565 570
28. Y. Fukuyama T. Mitsudomi K. Sugio K -ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer Br J Cancer 75 1997 1125 1130
29. H. Gahery Segard V. Molinier Frenkel C. Le Boulaire Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products J Clin Invest 100 1997 2218 2226
30. C.D. Gaynor F.X. McCormack D.R. Voelker Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages J Immunol 155 1995 5343 5351
31. Harlamert HA, Mira J, Bejarano PA, et al: Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinomas. Acta Cytologica, in press
32. J.B. Hibbs H.A. Chapman J.B. Weinberg The macrophage as an antineoplastic surveillance cell: Biological perspectives J Reticuloendothel Soc 24 1978 549 570
33. J.D. Iglehart M.J. Warzynski R.C. Montelaro Function of the secretory immune system in bronchogenic carcinoma: Immunoglobulin A levels in respiratory secretions J Thorac Cardiovasc Surg 82 1981 63 69
34. J.A. Kern R.J. Slebos B. Top C-erbB-2 expression and codon 12 K -ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas J Clin Invest 93 1994 516 520
35. E. Lemarie P. Carre M.F. Legrand Alveolar macrophage dysfunction in malignant lung tumors Thorax 39 1984 448 452
36. A.B. Lentsch M.J. Edwards D.E. Sims Interleukin-10 inhibits interleukin-2 induced tumor necrosis factor production but does not reduce toxicity in C3H/HeN mice J Leukoc Biol 60 1996 51 57
37. M. Levy E.P. Petreshock C. Mandell The response of the local immunoglobulin system to malignant lesions of the stomach: A new diagnostic test Cancer 36 1975 1991 1995
38. E.E. Lower R.P. Baughman Pulmonary lymphangitic metastasis from breast cancer. Lymphocytic alveolitis is associated with favorable prognosis Chest 102 1992 1113 1117
39. M.A. Mandel K.J. Dvorak L.W. Worman Immunoglobulin content in the bronchial washings of patients with benign and malignant pulmonary disease N Engl J Med 295 1976 694 698
40. T.W. Marcy W. Merrill J.A. Rankin Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage Am Rev Respir Dis 135 1987 1276 1280
41. C.F. McDonald R.C. Atkins Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer Chest 98 1990 881 885
42. C.F. McDonald P. Hutchinson R.C. Atkins Delineation of pulmonary alveolar macrophage subpopulations by flow cytometry in normal subjects and in patients with lung cancer Clin Exp Immunol 91 1993 126 130
43. N.E. Mills C.L. Fishman J. Scholes Detection of K -ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis [see comments] [published erratum appears in J Natl Cancer Inst 87:1643, 1995] J Natl Cancer Inst 87 1995 1056 1060
44. T. Mitsudomi S. Lam T. Shirakusa Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer [see comments] Chest 104 1993 362 365
45. T. Mitsudomi S.M. Steinberg H.K. Oie ras gene mutations in non–small cell lung cancers are associated with shortened survival irrespective of treatment intent Cancer Res 51 1991 4999 5002
46. D.R. Moller J.D. Forman M.C. Liu Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis J Immunol 156 1996 4952 4960
47. J.L. Mulshine F. Scott Molecular markers in early cancer detection. New screening tools Chest 107 1995 280S 286S
48. J.L. Mulshine J. Zhou A.M. Treston New approaches to the integrated management of early lung cancer Hematol Oncol Clin North Am 11 1997 235 252
49. I. Murakami Y. Fujiwara N. Yamaoka Detection of p53 gene mutations in cytopathology and biopsy specimens from patients with lung cancer Am J Respir Crit Care Med 154 1996 1117 1123
50. H. Nakamura S. Abe Y. Shibata Elevated levels of cytokeratin 19 in the bronchoalveolar lavage fluid of patients with chronic airway inflammatory diseases: A specific marker for bronchial epithelial injury Am J Respir Crit Care Med 155 1997 1217 1221
51. D.M. Nguyen F.R. Spitz N. Yen Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus–mediated p53 gene transfer J Thorac Cardiovasc Surg 112 1996 1372 1376
52. J. Niklinski E. Chyczewska M. Furman Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma Neoplasma 39 1992 283 285
53. U. Pastorino S. Andreola E. Tagliabue Immunocytochemical markers in stage I lung cancer: relevance to prognosis J Clin Oncol 15 1997 2858 2865
54. E.M. Pina D.A. Keeton R.P. Baughman Predictive value of IgA and IgG in bronchial samples of patients with lung cancer Am J Respir Crit Care Med 151 1995 A846
55. E.M. Pina E.E. Lower R.P. Baughman Prolonged survival in patients with pulmonary metastasis due to breast cancer is associated with lymphocytic alveolitis Am J Respir Crit Care Med 153 1996 A322
56. M. Pirozynski Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cancer Chest 102 1992 372 374
57. M. Pirozynski P. Sliwinski L. Radwan Bronchoalveolar lavage: Comparison of three commonly used procedures Respiration 58 1991 72 76
58. R.J. Pisani D.A. Cortese H.A. Homburger A prospective pilot study evaluating the effectiveness of secretory IgA measurements in bronchoalveolar lavage to detect non–small cell lung cancer Chest 97 1990 586 589
59. A.E. Pitchenik J. Guffee J. Stein Streilein Lung natural killer and interleukin-2 activity in lung cancer: A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma Am Rev Respir Dis 136 1987 1327 1332
60. M.C. Prados R. Alvarez Sala R. Blasco The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage Cancer 74 1994 1552 1555
61. S.S. Raab L.C. Berg P.E. Swanson Adenocarcinoma in the lung in patients with breast cancer. A prospective analysis of the discriminatory value of immunohistology [see comments] Am J Clin Pathol 100 1993 27 35
62. S.S. Raab D.D. Slagel J.H. Hughes Sensitivity and cost-effectiveness of fine-needle aspiration with immunocytochemistry in the evaluation of patients with a pulmonary malignancy and a history of cancer Arch Pathol Lab Med 121 1997 695 700
63. S.J. Radio S.I. Rennard A. Kessinger Breast carcinoma in bronchoalveolar lavage. A cytologic and immunocytochemical study Arch Pathol Lab Med 113 1989 333 336
64. S.I. Rennard Bronchoalveolar lavage in the diagnosis of cancer Lung 168 suppl 1990 1035 1040
65. S.I. Rennard M. Ghafouri A.B. Thompson Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples Am Rev Respir Dis 141 1990 208 217
66. H.Y. Reynolds Bronchoalveolar lavage Am Rev Respir Dis 135 1987 250 263
67. H.Y. Reynolds H.H. Newball Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage J Lab Clin Med 84 1974 559 570
68. B.W.S. Robinson P. Pinkston R.G. Crystal Natural killer cells are present in the normal lung but are functionally impotent J Clin Invest 74 1984 942 950
69. R. Rosell A. Pifarre M. Monzo Reduced survival in patients with stage-I non–small-cell lung cancer associated with DNA-replication errors Int J Cancer 74 1997 330 334
70. S.A. Rosenberg M.T. Lotze J.J. Mule New approaches to the immunotherapy of cancer using interleukin-2 Ann Intern Med 108 1988 853 864
71. J.A. Roth D. Nguyen D.D. Lawrence Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer Nat Med 2 1996 985 991
72. Y. Satoh Y. Ishikawa K. Nakagawa A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers Br J Cancer 75 1997 678 683
73. F. Scott F. Cuttitta A.M. Treston Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage J Cell Biochem Suppl 17F 1993 175 183
74. F.M. Scott A.M. Treston G.L. Shaw Peptide amidating activity in human bronchoalveolar lavage fluid Lung Cancer 14 1996 239 251
75. S. Shu G.E. Plautz J.C. Krauss Tumor immunology JAMA 278 1997 1972 1981
76. R.H. Simon J.F. Engelhardt Y. Yang Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study Hum Gene Ther 4 1993 771 780
77. R.J. Slebos R.E. Kibbelaar O. Dalesio K -ras oncogene activation as a prognostic marker in adenocarcinoma of the lung N Engl J Med 323 1990 561 565
78. J. Stein Streilein J. Guffee M. Ramos Spontaneous lymphokine activated killer (LAK) activity in bronchoalveolar lavage cells from patients with bronchogenic carcinoma Reg Immunol 2 1989 370 375
79. D.D. Stevens I.R. Mackay Increased carcinoembryonic antigen in heavy cigarette smokers Lancet 2 1973 1238 1239
80. K. Sugio T. Ishida H. Yokoyama ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis Cancer Res 52 1992 2903 2906
81. N. Sukoh S. Abe S. Ogura Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer Cancer 74 1994 46 51
82. S.G. Swisher S.M. Kiertscher S.H. Golub Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes Am J Respir Cell Mol Biol 8 1993 486 492
83. F. Tanaka M. Suga H. Nishikawa Effects of pulmonary surfactant on macrophage migration: Suppression of chemokinesis by surfactant phospholipid and enhancement of chemotaxis by surfactant protein Respirology 2 1997 119 126
84. M. Tateishi T. Ishida T. Mitsudomi Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung Cancer Res 50 1990 7077 7080
85. M.J. Thomassen D.P. Meeker J.M. Antal Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages Am J Respir Cell Mol Biol 7 1992 257 260
86. J.E. Thorpe R.P. Baughman P.T. Frame Bronchoalveolar lavage for diagnosing acute bacterial pneumonia J Infect Dis 155 1987 855 861
87. M.J. Tino J.R. Wright Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages Am J Physiol 270 1996 L677 L688
88. F. van Iwaarden B. Welmers J. Verhoef Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages Am J Respir Cell Mol Biol 2 1990 91 98
89. D. Walmrath A. Gunther H.A. Ghofrani Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis Am J Respir Crit Care Med 154 1996 57 62
90. J.C. Weissler M.F. Lipscomb V.M. Lem Tumor killing by human alveolar macrophages and blood monocytes: Decreased cytotoxicity of human alveolar macrophages Am Rev Respir Dis 134 1986 532 537
91. J.C. Weissler L.P. Nicod G.B. Toews Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma Am Rev Respir Dis 135 1987 1353 1357
92. L.J. Wesselius D.S. Dark F.N. Hanson Airway secretory IgA concentrations in patients with lung cancer. Evaluation of the uninvolved lung Chest 95 1989 1265 1268
93. R.W. Wilmott R.S. Amin C.R. Perez Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates Hum Gene Ther 7 1996 301 318
94. M.L. Wilsher D.J. Parker P.L. Haslam Immunosuppression by pulmonary surfactant: Mechanisms of action Thorax 45 1990 3 8
95. I. Yoshino M. Takenoyama H. Fujie The induction of cytotoxic T lymphocytes against HLA-A locus-matched lung adenocarcinoma in patients with non–small cell lung cancer Jpn J Cancer Res 88 1997 743 749
96. J. Zaleska M. Pirozynski S. Kwiek CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer Rocz Akad Med Bialymst supl 42 1997 179 189
97. J. Zeromski M.K. Gorny M. Wruk Behaviour of local and systemic immunoglobulins in patients with lung cancer Int Archs Allergy Appl Immun 49 1975 548 563